Chemodenervation in Urology

Meera Ganesh; Nicole Handa; Stephanie Kielb

doi:10.1016/j.ucl.2021.12.009

Chemodenervation in Urology

Urol Clin North Am. 2022 May;49(2):263-272. doi: 10.1016/j.ucl.2021.12.009.

Authors

Meera Ganesh¹, Nicole Handa², Stephanie Kielb³

Affiliations

¹ Northwestern University, Feinberg School of Medicine, 420 E Superior Street, Chicago, IL 60611, USA.
² Department of Urology, Feinberg School of Medicine, Northwestern University, 675 N St Clair Street, Suite 20-150, Chicago, IL 60611, USA.
³ Department of Urology, Feinberg School of Medicine, Northwestern University, 675 N St Clair Street, Suite 20-150, Chicago, IL 60611, USA. Electronic address: stephanie.kielb@nm.org.

PMID: 35428432
DOI: 10.1016/j.ucl.2021.12.009

Abstract

Onabotulinumtoxin A is an effective therapeutic tool for urologic treatment. The toxin exerts multiple effects in the urinary tract system, which contributes to its utility. The toxin can be used to alleviate a variety of pathologic conditions if administered in the appropriate patient population.

Keywords: Bladder injections; Botox; Detrusor overactivity; Intradetrusor injection; Overactive bladder.

Publication types

Review

MeSH terms

Botulinum Toxins, Type A* / therapeutic use
Female
Humans
Male
Nerve Block*
Neuromuscular Agents* / therapeutic use
Urinary Bladder, Neurogenic*
Urinary Bladder, Overactive* / drug therapy
Urology*

Substances

Neuromuscular Agents
Botulinum Toxins, Type A